Skip to content
StockMarketAgent
Healthcare / Diagnostics & ResearchUpdated 2026-05-10 22:07 UTC

WSE/BMX stock hub

WSE/BMX has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

WSE/BMXis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
48.5M
Warsaw Stock Exchange
Market data

Price

Recent price action with selectable time range.

WSE/BMXWSE/BMX
Loading chart…
In the news

Latest news · WSE/BMX

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 n/aP50 n/aP75 n/a
Trailing P/E461.6
P25 n/aP50 n/aP75 n/a
ROE0.2
P25 n/aP50 n/aP75 n/a
ROIC2.1
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All WSE/BMX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
195
Groups with data
11
Currency
PLN
Showing 195 of 195 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
Poland
Country code
PL
Employees
135
Enterprise value
PLN 63.3M
Exchange
Warsaw Stock Exchange
Financial currency
PLN
First seen
2026-05-10
Industry
Diagnostics & Research
Isin
PLBIOMX00015
Last refreshed
2026-05-10
Market cap
PLN 48.5M
Price
PLN 11.56
Price currency
PLN
Rev Per Employee
451,140.74x
Sector
Healthcare
Sic
3845
Symbol
wse/BMX
Website
https://www.biomaxima.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

11
MetricValue
Earnings Yield
0.22%
EV Earnings
603.12x
EV/EBIT
51.28x
EV/EBITDA
12.82x
EV/Sales
1.04x
P/B ratio
1.01x
P/E ratio
461.64x
P/S ratio
0.8x
PE Ratio10 Y
38.16x
PE Ratio3 Y
75.16x
PE Ratio5 Y
45.58x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

23
MetricValue
EBIT Margin
2.03%
EBITDA Margin
8.11%
Gross margin
46.72%
Gross Profit
PLN 28.5M
Gross Profit Growth
19.45%
Gross Profit Growth Q
18.46%
Gross Profit Growth3 Y
-22.96%
Gross Profit Growth5 Y
8.04%
Net Income
PLN 105,000
Net Income Growth Years
0%
Net Income Growth3 Y
-72.31%
Net Income Growth5 Y
-32.49%
Pretax Margin
0.31%
Profit Margin
0.17%
Profit Per Employee
PLN 778
Profitable Years
5
ROA
1
Roa5y
12.34
ROCE
1.98
ROE
0.22
Roe5y
31.71
ROIC
2.15
Roic5y
24.87

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

22
MetricValue
Cagr10y
10.27%
Cagr15y
3.44%
Cagr1y
-6.78%
Cagr3y
-24.04%
Cagr5y
-15.25%
Div CAGR10
9.6%
Div CAGR3
0%
Div CAGR5
14.87%
EPS Growth Years
0
EPS Growth3 Y
-72.03
EPS Growth5 Y
-32.8
FCF Growth3 Y
-79.26%
FCF Growth5 Y
-40.61%
OCF Growth10 Y
4.71%
OCF Growth3 Y
-59.29%
OCF Growth5 Y
-16.27%
Revenue Growth
17.5x
Revenue Growth Q
20.84x
Revenue Growth Quarters
7x
Revenue Growth Years
1x
Revenue Growth3 Y
-27.26x
Revenue Growth5 Y
4.97x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

12
MetricValue
Asset Turnover
PLN 0.79
Assets
PLN 77.5M
Current Assets
PLN 27.4M
Current Liabilities
PLN 19.5M
Equity
PLN 48.1M
Interest Coverage
0.96
Liabilities
PLN 29.4M
Long Term Assets
PLN 50M
Long Term Liabilities
PLN 9.9M
Tangible Book Value
PLN 48.1M
Tangible Book Value Per Share
PLN 11.47
WACC
6.09

Liquidity

Current-asset coverage and working-capital efficiency metrics.

3
MetricValue
Current ratio
1.74
Net Working Capital
PLN 11.1M
Working Capital
PLN 11.1M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

3
MetricValue
Buyback Yield
-0.01%
Dividend per share
PLN 0
Last Dividend
PLN 0.5

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
10Y total return
165.77%
1Y total return
-6.77%
200-day SMA
12.59
3Y total return
-56.18%
50-day SMA
11.73
50-day SMA vs 200-day SMA
50under200
5Y total return
-56.27%
All Time High
61
All Time High Change
-81.05%
All Time High Date
2020-07-29
All Time Low
2.88
All Time Low Change
301.39%
All Time Low Date
2014-12-02
ATR
0.25
Beta
0.33
Beta1y
0.19
Beta2y
0.15
Ch YTD
-4.07
High
11.64
High52
15.65
High52 Date
2025-06-04
High52ch
-26.13%
Low
11.4
Low52
10.7
Low52 Date
2025-12-18
Low52ch
8.04%
Ma50ch
-1.41%
Price vs 200-day SMA
-8.17%
RSI
44.33
RSI Monthly
41.01
RSI Weekly
40.15
Sharpe ratio
-0.24x
Sortino ratio
-0.15
Total Return
-0.01%
Tr YTD
-4.07
Tr15y
66.19%
Tr1m
0.52%
Tr1w
-1.87%
Tr3m
-10.73%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

5
MetricValue
Operating Income
PLN 1.2M
Operating Income Growth
264.9
Operating Income Growth3 Y
-67.37
Operating Income Growth5 Y
-26.16
Operating margin
2.03

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
2,688,783%
Net Borrowing
103,000
Shares Insiders
22.38%
Shares Out
4,193,118
Shares Qo Q
3.57%
Shares Yo Y
0.01%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

53
MetricValue
Average Volume
2,759.7x
Bv Per Share
11.47
Ch10y
140.8
Ch15y
45.59
Ch1m
0.52
Ch1w
-1.87
Ch1y
-6.77
Ch3m
-10.73
Ch3y
-57.11
Ch5y
-58.36
Ch6m
-11.08
Change
-0.69%
Change From Open
-0.69
Close
11.64
Days Gap
0
Depreciation Amortization
3,293,000
Dollar Volume
21,813.7
Earnings Date
2026-04-30
EBIT
PLN 1.2M
EBITDA
PLN 4.9M
EPS
PLN 0.03
F Score
5
Financing CF
-3,845,000
Fiscal Year End
December
Founded
1,997
Graham Number
2.54166
Graham Upside
-78.01
Income Tax
PLN 83,000
Investing CF
1,299,000
Is Primary Listing
1
Last Earnings Date
2026-04-30
Last Report Date
2025-09-30
Lynch Fair Value
PLN 0.13
Lynch Upside
-98.92
Ma150
12.35
Ma150ch
-6.37%
Ma20
11.68
Ma20ch
-0.99%
Net CF
828,000
Next Earnings Date
2026-05-29
Open
11.64
P OCF Ratio
14.37
Position In Range
66.67
Ppne
49,283,000
Price Date
2026-05-08
Price EBITDA
PLN 9.81
Ptbv Ratio
1.01
Relative Volume
0.69x
Revenue
60,904,000x
Tax By Revenue
0.14x
Tax Rate
44.15%
Tr6m
-11.08%
Volume
1,887
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does WSE/BMX pay a dividend?

Capital-return profile for this ticker.

Performance

WSE/BMX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-6.8%
S&P 500 1Y: n/a
3Y total return
-56.2%
S&P 500 3Y: n/a
5Y total return
-56.3%
S&P 500 5Y: n/a
10Y total return
+165.8%
S&P 500 10Y: n/a
Ownership

Who owns WSE/BMX?

Insider, institutional, and short-interest positioning.

Institutional ownership
n/a
Share of float held by funds and institutions
Insider ownership
+22.4%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+0.0%
Negative means the company is buying back shares.
Technical

WSE/BMX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
44.3
Neutral momentum band
Price vs 200-day MA
-8.2%
50/200-day relationship not available
Beta (5Y)
0.33
Less volatile than the market
Sharpe ratio
-0.24
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About WSE/BMX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current wse/BMX stock rating?

wse/BMX is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full wse/BMX analysis?

The full report lives at /stocks/wse/BMX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for wse/BMX?

The latest report frames wse/BMX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the wse/BMX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.